Back to Search
Start Over
Rate of serious infections in Behçet's disease patients receiving biologic therapies: a prospective observational study.
- Source :
-
Clinical rheumatology [Clin Rheumatol] 2013 Oct; Vol. 32 (10), pp. 1547-8. Date of Electronic Publication: 2013 May 26. - Publication Year :
- 2013
- Subjects :
- Adalimumab
Adult
Antibodies, Monoclonal adverse effects
Antibodies, Monoclonal, Humanized adverse effects
Female
Humans
Infections etiology
Inflammation
Infliximab
Male
Middle Aged
Prospective Studies
Research Design
Risk
Time Factors
Behcet Syndrome complications
Behcet Syndrome therapy
Biological Products adverse effects
Biological Therapy adverse effects
Infections complications
Subjects
Details
- Language :
- English
- ISSN :
- 1434-9949
- Volume :
- 32
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Clinical rheumatology
- Publication Type :
- Academic Journal
- Accession number :
- 23708830
- Full Text :
- https://doi.org/10.1007/s10067-013-2290-7